Cochlear Limited is a leading global provider of implantable hearing solutions, specializing in cochlear implant systems, bone conduction devices, and sound processor upgrades. Headquartered in Sydney... Cochlear Limited is a leading global provider of implantable hearing solutions, specializing in cochlear implant systems, bone conduction devices, and sound processor upgrades. Headquartered in Sydney, Australia, the company has over 40 years of experience and holds approximately 60% of the global cochlear implant market share. Cochlear Limited serves both developed and emerging markets, with a strong focus on children and adults experiencing severe to profound hearing loss. Its products are distributed across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific region. Listed on the CHI-X Market Australia – Limit Venue, Cochlear Limited operates within the healthcare sector and is recognized for its innovation, robust financial performance, and significant contribution to improving hearing outcomes worldwide. The company’s shares are actively traded, reflecting its prominence in the medical technology industry.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

No Waste Management data disclosed by Cochlear

We reviewed Cochlear's website and available disclosure materials for the 2024 reporting period and did not identify any reported Waste Management data.

If you would like us to review newly published materials or reassess the most recent disclosures, you can submit a data update request.

Would you like us to review Cochlear's data?

Start your 30-day free trial to request a data review for Cochlear.

Start Free Trial

Legal Center Contact Us